Meta-analysis of genetic variability in the β-amyloid production, aggregation and degradation metabolic pathways and the risk of Alzheimer's disease

Acta Neurologica Scandinavica

Volumn 117, Issue 1, 2008, Pages 1-14

  Llorca, J ^a,d   Rodriguez Rodriguez E ^b   Dierssen Sotos, T ^a   Delgado Rodriguez M ^c   Berciano, J ^b   Combarros, O ^b  

^a UNIVERSITY OF CANTABRIA   (Spain)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^c UNIVERSITY OF JAÉN   (Spain)

^d UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

amyloid; Alzheimer's disease; Epidemiology; Meta analysis; Polymorphism (genetics)

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; BLEOMYCIN HYDROLASE; CYTOCHROME P 450 6; CYTOCHROME P450; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ALZHEIMER DISEASE; ARTICLE; EXON; GENETIC VARIABILITY; GENOTYPE; HUMAN; INTRON; PROTEIN AGGREGATION; PROTEIN DEGRADATION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID PRECURSOR PROTEIN SECRETASES; ASIAN CONTINENTAL ANCESTRY GROUP; ASPARTIC ENDOPEPTIDASES; BRAIN; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; POLYMORPHISM, GENETIC; RECEPTORS, LDL; SCAVENGER RECEPTORS, CLASS E; VARIATION (GENETICS);

EID: 37249065259     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2007.00899.x     Document Type: Article

References (84)

1. Combarros O, Alvarez-Arcaya A, Sánchez-Guerra M, Infante J, Berciano J. Candidate gene association studies in sporadic Alzheimer's disease. Dement Geriatr Cogn Disord 2002 14 : 41 54.
2. Bertram L, McQueen M, Mullin K, Blacker D, Tanzi R. The AlzGene Database. Alzheimer Research Forum. Available at: http://www.alzgene.org. Accessed: 3 August 2006.
3. Papassotiropoulos A, Wollmer MA, Tsolaki M, et al. A cluster of cholesterol-related genes confers susceptibility for Alzheimer's disease. J Clin Psychiatry 2005 66 : 940 7.
4. Mattson MP. Pathways towards and away from Alzheimer's disease. Nature 2004 430 : 631 9.
5. Tanzi RE, Moir RD, Wagner SL. Clearance of Alzheimer's Aβ peptide: the many roads to perdition. Neuron 2004 43 : 605 8.
6. Ntais C, Polycarpou A, Ioannidis JPA. Meta-analysis of the association of the cathepsin D Ala224Val gene polymorphism with the risk of Alzheimer's disease: a HuGE gene-disease association review. Am J Epidemiol 2004 159 : 527 36.
7. Bertram L, Parkinson M, McQueen MB, et al. Further evidence for LBP-1c/CP2/LSF association in Alzheimer's disease families. J Med Genet 2005 42 : 857 62.
8. Dermaut B, Roks G, Theuns J, et al. Variable expression of presenilin 1 is not a major determinant of risk for late-onset Alzheimer's disease. J Neurol 2001 248 : 935 9.
9. Lehmann DJ, Williams J, McBroom J, Smith AD. Using meta-analysis to explain the diversity of results in genetic studies of late-onset Alzheimer's disease and to identify high-risk subgroups. Neuroscience 2001 108 : 541 54.
10. Del Bo R, Scarlato M, Ghezzi S, et al. Is M129V of PRNP gene associated with Alzheimer's disease? A case-control study and a meta-analysis. Neurobiol Aging 2006 27 : 770.e1 770.e5, in press.
11. Koster MN, Dermaut B, Cruts M, et al. The α2-macroglobulin gene in AD. A population-based study and meta-analysis. Neurology 2000 55 : 678 84.
12. Pritchard A, Harris J, Pritchard CW, et al. Association study and meta-analysis of low-density lipoprotein receptor related protein in Alzheimer's disease. Neurosci Lett 2005 382 : 221 6.
13. Cruts M, Dermaut B, Rademakers R, et al. Amyloid β secretase gene (BACE) is neither mutated in nor associated with early-onset Alzheimer's disease. Neurosci Lett 2001 313 : 105 7.
14. Murphy T, Yip A, Brayne C, Easton D, et al. The BACE gene: genomic structure and candidate gene study in late-onset Alzheimer's disease. Neuroreport 2001 12 : 631 4.
15. Nowotny P, Kwon JM, Chakraverty S, Nowotny V, Morris JC, Goate AM. Association studies using novel polymorphisms in BACE1 and BACE2. Neuroreport 2001 12 : 1799 802.
16. Clarimon J, Bertranpetit J, Calafell F, Boada M, Tarraga L, Comas D. Association study between Alzheimer's disease and genes involved in Aβ biosynthesis, aggregation and degradation: suggestive results with BACE1. J Neurol 2003 250 : 956 61.
17. Gold G, Blouin JL, Herrmann FR, et al. Specific BACE1 genotypes provide additional risk for late-onset Alzheimer disease in APOE ε4 carriers. Am J Med Genet B 2003 119B : 44 7.
18. Kirschling CM, Kolsch H, Frahnert C, Rao ML, Maier W, Heun R. Polymorphism in the BACE gene influences the risk for Alzheimer's disease. Neuroreport 2003 14 : 1243 6.
19. Liu HC, Leu SJ, Chang JG, et al. The association of beta-site APP cleaving enzyme (BACE) C786 G polymorphism with Alzheimer's disease. Brain Res 2003 961 : 88 91.
20. Shi J, Zhang S, Tang M, et al. The 1239 G/C polymorphism in exon 5 of BACE1 gene may be associated with sporadic Alzheimer's disease in Chinese Hans. Am J Med Genet B 2004 124B : 54 7.
21. Hu Q, Kukull WA, Bressler SL, et al. The human FE65 gene: genomic structure and an intronic biallelic polymorphism associated with sporadic dementia of the Alzheimer type. Hum Genet 1998 103 : 295 303.
22. Guenette SY, Bertram L, Crystal A, et al. Evidence against association of the FE65 gene (APBB1) intron 13 polymorphism in Alzheimer's patients. Neurosci Lett 2000 296 : 17 20.
23. Lambert JC, Mann D, Goumidi L, et al. A FE65 polymorphism associated with risk of developing sporadic late-onset Alzheimer's disease but not with Aβ loading in brains. Neurosci Lett 2000 293 : 29 32.
24. Papassotiropoulos A, Bagli M, Becker K, et al. No association between an intronic biallelic polymorphism of the FE65 gene and Alzheimer's disease. Int J Mol Med 2000 6 : 587 9.
25. Prince JA, Feuk L, Sawyer SL, et al. Lack of replication of association findings in complex disease: an analysis of 15 polymorphims in prior candidate genes for sporadic Alzheimer's disease. Eur J Hum Genet 2001 9 : 437 44.
26. Cousin E, Hannequin D, Ricard S, et al. A risk for early-onset Alzheimer's disease associated with de APBB1 gene (FE65) intron 13 polymorphism. Neurosci Lett 2003 342 : 5 8.
27. Desai P, DeKosky ST, Kamboh MI. Genetic variation in the cholesterol 24-hydroxylase (CYP46) gene and the risk of Alzheimer's disease. Neurosci Lett 2002 328 : 9 12.
28. Kolsch H, Lutjohann D, Ludwig M, et al. Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease. Mol Psychiatry 2002 7 : 899 902.
29. Papassotiropoulos A, Streffer JR, Tsolaki M, et al. Increased brain β-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism. Arch Neurol 2003 60 : 29 35.
30. Borroni B, Archetti S, Agosti C, et al. Intronic CYP46 polymorphism along with ApoE genotype in sporadic Alzheimer disease: from risk factors to disease modulators. Neurobiol Aging 2004 25 : 747 51.
31. Chalmers KA, Culpan D, Kehoe PG, Wilcock GK, Hughes A, Love S. APOE promoter, ACE1, and CYP46 polymorphisms and β-amyloid in Alzheimer's disease. Neuroreport 2004 15 : 95 8.
32. Combarros O, Infante J, Llorca J, Berciano J. Genetic association of CYP46 and risk for Alzheimer's disease. Dement Geriatr Cogn Disord 2004 18 : 257 60.
33. Ingelsson M, Jesneck J, Irizarry MC, Hyman BT, Rebeck GW. Lack of association of the cholesterol 24-hydroxylase (CYP46) intron 2 polymorphism with Alzheimer's disease. Neurosci Lett 2004 367 : 228 31.
34. Johansson A, Katzov H, Zetterberg H, et al. Variants of CYP46A1 may interact with age and APOE to influence CSF Aβ42 levels in Alzheimer's disease. Hum Genet 2004 114 : 581 7.
35. Kabbara A, Payet N, Cottel D, Frigard B, Amouyel P, Lambert JC. Exclusion of CYP46 and APOM as candidate genes for Alzheimer's disease in a French population. Neurosci Lett 2004 363 : 139 43.
36. Wang B, Zhang C, Zheng W, et al. Association between a T/C polymorphism in intron 2 of cholesterol 24S-hydroxylase gene and Alzheimer's disease in Chinese. Neurosci Lett 2004 369 : 104 7.
37. Golanska E, Hulas-Bigoszewska K, Wojcik I, et al. CYP46: A risk factor for Alzheimer's disease or a coincidence? Neurosci Lett 2005 383 : 105 8.
38. Tedde A, Rotondi M, Cellini E, et al. Lack of association between the CYP46 gene polymorphism and Italian late-onset sporadic Alzheimer's disease. Neurobiol Aging 2006 27 : 773.el e3.
39. Luedecking-Zimmer E, DeKosky ST, Chen Q, Barmada MM, Kamboh MI. Investigation of oxidized LDL-receptor 1 (OLR1) as the candidate gene for Alzheimer's disease on chromosome 12. Hum Genet 2002 111 : 443 51.
40. Lambert JC, Luedecking-Zimmer E, Merrot S, et al. Association of 3′-UTR polymorphisms of the oxidised LDL receptor 1 (OLR1) gene with Alzheimer's disease. J Med Genet 2003 40 : 424 30.
41. Pritchard A, St Clair D, Lemmon H, Mann DM, Lendon C. No association between polymorphisms in the lectin-like oxidised low density lipoprotein receptor (ORL1) gene on chromosome 12 and Alzheimer's disease in a UK cohort. Neurosci Lett 2004 366 : 126 9.
42. D'Introno A, Solfrizzi V, Colacicco AM, et al. Polymorphisms in the oxidized low-density lipoprotein receptor-1 gene and risk of Alzheimer's disease. J Gerontol A Biol Sci Med Sci 2005 60 : 280 4.
43. Okuizumi K, Onodera O, Seki K, et al. Lack of association of very low density lipoprotein receptor gene polymorphism with Caucasian Alzheimer's disease. Ann Neurol 1996 40 : 251 4.
44. Chen L, Baum L, Ng HK, et al. No association detected between very-low-density lipoprotein receptor (VLDL-R) and late-onset Alzheimer's disease in Hong Kong Chinese. Neurosci Lett 1998 241 : 33 6.
45. Helbecque N, Richard F, Cottel D, Neuman E, Guez D, Amouyel P. The very low density lipoprotein (VLDL) receptor is a genetic susceptibility factor for Alzheimer disease in a European Caucasian population. Alzheimer Dis Assoc Disord 1998 12 : 368 71.
46. Yamanaka H, Kamimura K, Tanahashi H, Takahashi K, Asada T, Tabira T. Genetic risk factors in Japanese Alzheimer's disease patients: alpha1-ACT, VLDLR, and ApoE. Neurobiol Aging 1998 19 : S43 6.
47. McIlroy SP, Vahidassr MD, Savage DA, Patterson CC, Lawson JT, Passmore AP. Risk of Alzheimer's disease is associated with a very low-density lipoprotein receptor genotype in Northern Ireland. Am J Med Genet 1999 8 : 140 4.
48. Perry RT, Collins JS, Harrell LE, Acton RT, Go RC. (2001). Investigation of association of 13 polymorphisms in eight genes in southeastern African American Alzheimer disease patients as compared to age-matched controls. Am J Med Genet 2001 105 : 332 42.
49. Haines JL, Pritchard ML, Saunders AM, et al. No association between alpha 1-antichymotrypsin and familial Alzheimer's disease. Ann N Y Acad Sci 1996 802 : 35 41.
50. Muller U, Bodeker RH, Gerundt I, Kurz A. Lack of association between alpha 1-antichymotrypsin polymorphism, Alzheimer's disease, and allele epsilon 4 of apolipoprotein E. Neurology 1996 47 : 1575 7.
51. Muramatsu T, Matsushita S, Arai H, Sasaki H, Higuchi S. Alpha 1-antichymotrypsin gene polymorphism and risk for Alzheimer's disease. J Neural Transm 1996 103 : 1205 10.
52. Didierjean O, Martinez M, Campion D, et al. No effect of the alpha1-antichymotrypsin A allele in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1997 63 : 103 5.
53. Fallin D, Reading S, Schinka J, et al. No interaction between the APOE and the alpha-1-antichymotrypsin genes on risk for Alzheimer's disease. Am J Med Genet 1997 74 : 192 4.
54. Helisalmi S, Mannermaa A, Lehtovirta M, Ryynanen M, Riekkinen P Sr., Soininen H. No association between alpha1-antichymotrypsin polymorphism, apolipoprotein E and patients with late-onset Alzheimer's disease. Neurosci Lett 1997 231 : 56 8.
55. Murphy GM Jr., Sullivan EV, Gallagher-Thompson D, et al. No association between the alpha 1-antichymotrypsin A allele and Alzheimer's disease. Neurology 1997 48 : 1313 6.
56. Tysoe C, Galinsky D, Robinson D, et al. Analysis of alpha-1 antichymotrypsin, presenilin-1, angiotensin-converting enzyme, and methylenetetrahydrofolate reductase loci as candidates for dementia. Am J Med Genet 1997 74 : 207 12.
57. Yoshiiwa A, Kamino K, Yamamoto H, et al. alpha 1-Antichymotrypsin as a risk modifier for late-onset Alzheimer's disease in Japanese apolipoprotein E epsilon 4 allele carriers. Ann Neurol 1997 42 : 115 7.
58. Yoshizawa T, Yamakawa-Kobayashi K, Hamaguchi H, Shoji S. Alpha1-antichymotrypsin polymorphism in Japanese cases of Alzheimer's disease. J Neurol Sci 1997 152 : 136 9.
59. Ezquerra M, Blesa R, Tolosa E, Ballesta F, Oliva R. Alpha- antichymotrypsin gene polymorphism and risk for Alzheimer's disease in the Spanish population. Neurosci Lett 1998 240 : 107 9.
60. Itabashi S, Arai H, Matsui T, et al. Absence of association of alpha1-antichymotrypsin polymorphisms with Alzheimer's disease: a report on autopsy-confirmed cases. Exp Neurol 1998 151 : 237 40.
61. Lamb H, Christie J, Singleton AB, et al. Apolipoprotein E and alpha-1 antichymotrypsin polymorphism genotyping in Alzheimer's disease and in dementia with Lewy bodies. Distinctions between diseases. Neurology 1998 50 : 388 91.
62. Nacmias B, Marcon G, Tedde A, et al. Implication of alpha1- antichymotrypsin polymorphism in familial Alzheimer's disease. Neurosci Lett 1998 244 : 85 8.
63. Licastro F, Pedrini S, Govoni M, et al. Apolipoprotein E and alpha-1-antichymotrypsin allele polymorphism in sporadic and familial Alzheimer's disease. Neurosci Lett 1999 270 : 129 32.
64. Schwab SG, Bagli M, Papassotiropoulos A, et al. Alpha-1-antichymotrypsin gene polymorphism and risk for sporadic Alzheimer's disease in a German population. Dement Geriatr Cogn Disord 1999 10 : 469 72.
65. Sodeyama N, Yamada M, Itoh Y, et al. Lack of genetic associations of alpha-1-antichymotrypsin polymorphism with alzheimer-type neuropathological changes or sporadic Alzheimer's disease. Dement Geriatr Cogn Disord 1999 10 : 221 5.
66. Wang YC, Liu TY, Liu HC, et al. No association between alpha-1-antichymotrypsin polymorphism and Alzheimer's disease in Chinese. Neuropsychobiology 1999 40 : 67 70.
67. Kim KW, Jhoo JH, Lee KU, et al. No association between alpha-1-antichymotrypsin polymorphism and Alzheimer's disease in Koreans. Am J Med Genet 2000 91 : 355 8.
68. Rodriguez Martin T, Calella AM, Silva S, et al. Apolipoprotein E and intronic polymorphism of presenilin 1 and alpha-1-antichymotrypsin in Alzheimer's disease and vascular dementia. Dement Geriatr Cogn Disord 2000 11 : 239 44.
69. Tang G, Jiang S, Zhang M, et al. Genetic association study between alpha 1-antichymotrypsin polymorphism and Alzheimer disease in Chinese Han population. Am J Med Genet 2000 96 : 133 5.
70. Ki CS, Na DL, Kim HJ, Kim JW. Alpha-1 antichymotrypsin and alpha-2 macroglobulin gene polymorphisms are not associated with Korean late-onset Alzheimer's disease. Neurosci Lett 2001 302 : 69 72.
71. Retz W, Thome J, Durany N, et al. Potential genetic markers of sporadic Alzheimer's dementia. Psychiatr Genet 2001 11 : 115 22.
72. Wang X, DeKosky ST, Luedecking-Zimmer E, Ganguli M, Kamboh IM. Genetic variation in alpha(1)-antichymotrypsin and its association with Alzheimer's disease. Hum Genet 2002 11 : 356 65.
73. Hernandez-Charro B, Moreno S, Valiente A, Manubens JM, Villar MD, Ramos-Arroyo MA. El polimorfismo ACT/AA puede duplicar el riesgo de enfermedad de Alzheimer asociado a la APOE ε4. Med Clin (Barc) 2004 123 : 251 4.
74. Farrer LA, Abraham CR, Haines JL, et al. Association between bleomycin hydrolase and Alzheimer's disease in caucasians. Ann Neurol 1998 44 : 808 11.
75. Montoya SE, Aston CE, DeKosky ST, Kamboh MI, Lazo JS, Ferrell RE. Bleomycin hydrolase is associated with risk of sporadic Alzheimer's disease. Nat Genet 1998 18 : 211 2.
76. Namba Y, Ouchi Y, Asada T, Hattori H, Ueki A, Ikeda K. Lack of association between bleomycin hydrolase gene polymorphism and Alzheimer's disease in Japanese people. Ann Neurol 1999 46 : 136 7.
77. Thome J, Gewirtz JC, Sakai N, et al. Polymorphisms of the human apolipoprotein E promoter and bleomycin hydrolase gene: risk factors for Alzheimer's dementia? Neurosci Lett 1999 274 : 37 40.
78. Papassotiropoulos A, Bagli M, Jessen F, et al. Confirmation of the association between bleomycin hydrolase genotype and Alzheimer's disease. Mol Psychiatry 2000 5 : 213 5.
79. Dietschy JM, Turley SD. Cholesterol metabolism in the brain. Curr Opin Lipidol 2001 12 : 105 12.
80. Morán MA, Mufson EJ, Gómez-Ramos P. Colocalization of cholinesterases with β amyloid protein in aged and Alzheimer's brains. Acta Neuropathol 1993 85 : 362 9.
81. Ferrer I, Blanco R, Carmona M, et al. Prion protein expression in senile plaques in Alzheimer's disease. Acta Neuropathol 2001 101 : 49 56.
82. Irizarry MC, Deng A, Lleo A, et al. Apolipoprotein E modulates γ-secretase cleavage of the amyloid precursor protein. J Neurochem 2004 90 : 1132 43.
83. Helbecque N, Amouyel P. Very low density lipoprotein receptor in Alzheimer disease. Microsc Res Tech 2000 50 : 273 7.
84. Salanti G, Amountza G, Ntzani EE, Ioannidis JP. Hardy-Weinberg equilibrium in genetic association studies: an empirical evaluation of reporting, deviations, and power. Eur J Hum Genet 2005 13 : 840 8.